semaglutide 2025 ACC 2025: Oral Reduces Cardiovascular Events by 14% at 4 Years Novo cuts GLP-1 prices 70%,

2 In separate clinical studies of adults with overweight or obesity, about 1 in 4 taking Wegovy oral semaglutide 25 mg (64 weeks), about 1 in 3 taking Wegovy injection 2.4 mg (68 weeks), and about 1 in 2 taking Wegovy injection 7.2 mg (72 weeks) lost 20% of body weight, alongside diet and exercise

We recommend limiting alcohol intake and discussing your specific situation with your provider

Ask for a Certificate of Analysis (CoA): Reputable pharmacies test their compounded batches for sterility, purity, and potency through independent, third-party laboratories

How does semaglutides weight loss benefit compare to other GLP-1 medications like Ozempic

Always eat before drinking and monitor how you feel